UBS raised the firm’s price target on Charles River (CRL) to $250 from $240 and keeps a Buy rating on the shares post the earnings report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Charles River Laboratories Reports 2024 Q3 Financial Results
- Charles River upgraded to Hold from Underperform at CLSA
- Charles River price target raised to $211 from $190 at Baird
- Early notable gainers among liquid option names on November 6th
- Charles River raises FY24 EPS view to $10.10-$10.30 from $9.90-$10.20